uniQure N.V.·4

Jun 12, 6:04 PM ET

Gut Robert 4

Research Summary

AI-generated summary

Updated

uniQure (QURE) Director Robert Gut Exercises Options and Sells Shares

What Happened

  • Robert Gut, a director of uniQure N.V. (QURE), exercised stock options to acquire 2,645 shares (exercise price $16.04; total cost $42,426) and then sold shares in the open market.
  • Open-market sales on June 10–11, 2026 totaled 10,278 shares for combined gross proceeds of approximately $270,486 (sales at roughly $26.01–$27.25 per share).
  • The filing also reports grants/awards totaling 21,530 shares (7,550 and 13,980 units) as awards/derivative acquisitions (restricted share units / awards subject to vesting).

Key Details

  • Dates: primary transactions occurred June 10, 2026 (exercise, sales, grants) and June 11, 2026 (additional sale); report filed June 12, 2026 (timely).
  • Sales detail (cash proceeds):
    • 2,645 shares sold @ $26.07 = $68,955
    • 3,127 shares sold @ $26.03 = $81,396
    • 1,780 shares sold @ $26.05 = $46,369
    • 2,726 shares sold @ $27.06 = $73,766
      (weighted-price ranges reported in the filing for the various blocks: approx. $26.01–$27.25)
  • Option exercise: 2,645 shares acquired by exercise at $16.04 per share ($42,426). Some derivative entries in the filing reflect the mechanics of option conversion/exercise.
  • Awards: 7,550 restricted share units (RSUs) and 13,980 units shown as grants/derivative acquisitions; RSUs vesting terms cited in the filing (vesting schedules apply).
  • Automatic withholding sale: one sale block was reported as an automatic sale on vesting to cover withholding taxes (not a discretionary trade).
  • Plan / compliance: transactions were effected under a Rule 10b5-1 sales plan adopted July 8, 2025.
  • Shares owned after the transactions: not specified in the excerpt provided (aggregate holdings not included here).

Context

  • This was primarily a sale of shares and represents routine monetization activity rather than a clear directional signal about company prospects. The sequence — exercise of options followed by sales the same day — is consistent with a cashless exercise/monetization.
  • The presence of a 10b5-1 plan and an automatic tax-withholding sale are common mechanisms for insiders to sell shares while avoiding timing concerns; they do not necessarily indicate a change in the insider’s view of the company.